Brian C Stephenson insider trades: Faeth Therapeutics (FTH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | FTH | ↑ Buy | 13,634 | $23.92 | $326K | Indirect | Jul 1, 2026 (0d) |
| Jun 26, 2026 | FTH | ↑ Buy | 15,641 | $25.65 | $401K | Indirect | Jun 26, 2026 (0d) |
| Jun 23, 2026 | FTH | ↑ Buy | 17,413 | $23.31 | $406K | Indirect | Jun 24, 2026 (1d) |
| Feb 25, 2025 | BBIO | ↓ Sell | 8,500 | $33.19 | $282K | Direct | Feb 27, 2025 (2d) |
| Feb 19, 2025 | BBIO | ↓ Sell | 4,148 | $36.16 | $150K | Direct | Feb 19, 2025 (0d) |
| Jan 28, 2025 | BBIO | ↓ Sell | 68,000 | $36.29 | $2.5M | Direct | Jan 30, 2025 (2d) |
| Nov 19, 2024 | BBIO | ↓ Sell | 4,156 | $22.41 | $93K | Direct | Nov 20, 2024 (1d) |
| Aug 19, 2024 | BBIO | ↓ Sell | 4,155 | $24.69 | $103K | Direct | Aug 20, 2024 (1d) |
| Nov 17, 2023 | BBIO | ↓ Sell | 22,685 | $29.10 | $660K | Direct | Nov 20, 2023 (3d) |
| Aug 17, 2023 | BBIO | ↓ Sell | 22,683 | $28.59 | $648K | Direct | Aug 18, 2023 (1d) |
| May 17, 2023 | BBIO | ↓ Sell | 24,424 | $14.01 | $342K | Direct | May 18, 2023 (1d) |
| May 3, 2023 | BBIO | ↓ Sell | 64,929 | $14.18 | $921K | Direct | May 5, 2023 (2d) |
| Apr 5, 2023 | BBIO | ↓ Sell | 55,500 | $15.45 | $858K | Direct | Apr 7, 2023 (2d) |
| Mar 3, 2023 | BBIO | ↓ Sell | 62,692 | $10.96 | $687K | Direct | Mar 3, 2023 (0d) |
| Feb 17, 2023 | BBIO | ↓ Sell | 17,717 | $12.70 | $225K | Direct | Feb 21, 2023 (4d) |
| Feb 3, 2023 | BBIO | ↓ Sell | 61,040 | $11.01 | $672K | Direct | Feb 6, 2023 (3d) |
| Jan 5, 2023 | BBIO | ↓ Sell | 61,040 | $7.67 | $468K | Direct | Jan 6, 2023 (1d) |
| Nov 17, 2022 | BBIO | ↓ Sell | 19,678 | $9.40 | $185K | Direct | Nov 18, 2022 (1d) |
| Feb 17, 2021 | BBIO | ↑ Buy | 8,000 | $62.50 | $500K | Direct | Feb 18, 2021 (1d) |
| Aug 4, 2020 | BBIO | ↓ Sell | 7,200 | $27.26 | $196K | Direct | Aug 5, 2020 (1d) |
| Jul 1, 2020 | BBIO | ↓ Sell | 10,800 | $30.93 | $334K | Direct | Jul 6, 2020 (5d) |
| Jun 8, 2020 | BBIO | ↓ Sell | 2,000 | $30.00 | $60K | Direct | Jun 10, 2020 (2d) |
| Jun 3, 2020 | BBIO | ↓ Sell | 1,600 | $30.04 | $48K | Direct | Jun 5, 2020 (2d) |
| Jun 1, 2020 | BBIO | ↓ Sell | 7,200 | $29.36 | $211K | Direct | Jun 3, 2020 (2d) |
| May 5, 2020 | BBIO | ↓ Sell | 5,706 | $30.49 | $174K | Direct | May 6, 2020 (1d) |
| May 4, 2020 | BBIO | ↓ Sell | 8,694 | $29.37 | $255K | Direct | May 5, 2020 (1d) |
| Apr 1, 2020 | BBIO | ↓ Sell | 7,200 | $26.61 | $192K | Direct | Apr 3, 2020 (2d) |
| Mar 2, 2020 | BBIO | ↓ Sell | 10,800 | $32.27 | $349K | Direct | Mar 4, 2020 (2d) |
| Feb 4, 2020 | BBIO | ↓ Sell | 10,800 | $34.73 | $375K | Direct | Feb 5, 2020 (1d) |
| Jan 3, 2020 | BBIO | ↓ Sell | 10,800 | $32.93 | $356K | Direct | Jan 6, 2020 (3d) |
| Jul 1, 2019 | BBIO | ↑ Buy | 55,500 | $17.00 | $944K | Direct | Jul 3, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other FTH insiders
Open-market trades in the last 12 months
About Brian C Stephenson's insider trades
Brian C Stephenson is Chief Financial Officer at Faeth Therapeutics (FTH). Since Jul 1, 2019, Brian has reported 5 open-market purchases worth $2.6M and 26 sales worth $11.3M on SEC Form 4. In the last 12 months: 3 buys ($1.1M).
Their filings also include option exercises (22 filings), shares withheld for taxes (19 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FTH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.